Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Evaluation of Copper Chelation Therapy in a Transgenic Rat Model of Cerebral Amyloid Angiopathy

Journal Article · · ACS Chemical Neuroscience
 [1];  [2];  [3];  [4];  [2];  [2];  [1]
  1. Stony Brook Univ., NY (United States); Brookhaven National Lab. (BNL), Upton, NY (United States). National Synchrotron Light Source II (NSLS-II)
  2. Univ. of Rhode Island, Kingston, RI (United States)
  3. Brookhaven National Lab. (BNL), Upton, NY (United States). National Synchrotron Light Source II (NSLS-II)
  4. Brookhaven National Lab. (BNL), Upton, NY (United States). National Synchrotron Light Source II (NSLS-II); Virginia Polytechnic Inst. and State Univ. (Virginia Tech), Blacksburg, VA (United States)
Cerebral amyloid angiopathy (CAA) is characterized by the accumulation of the amyloid β (Aβ) protein in blood vessels and leads to hemorrhages, strokes, and dementia in elderly individuals. Recent reports have shown elevated copper levels colocalized with vascular amyloid in human CAA and Alzheimer’s disease patients, which have been suggested to contribute to cytotoxicity through the formation of reactive oxygen species. Here, we treated a transgenic rat model of CAA (rTg-DI) with the copper-specific chelator, tetrathiomolybdate (TTM), via intraperitoneal (IP) administration for 6 months to determine if it could lower copper content in vascular amyloid deposits and modify CAA pathology. In this work, results showed that TTM treatment led to elevated Aβ load in the hippocampus of the rTg-DI rats and increased microbleeds in the wild type (WT) animals. X-ray fluorescence microscopy was performed to image the distribution of copper and revealed a surprising increase in copper colocalized with Aβ aggregates in TTM-treated rTg-DI rats. Unexpectedly, we also found an increase in the copper content in unaffected vessels of both rTg-DI and WT animals. These results show that IP administration of TTM was ineffective in removing copper from vascular Aβ aggregates in vivo and increased the development of disease pathology in CAA.
Research Organization:
Argonne National Laboratory (ANL), Argonne, IL (United States). Advanced Photon Source (APS); Brookhaven National Laboratory (BNL), Upton, NY (United States). National Synchrotron Light Source II (NSLS-II)
Sponsoring Organization:
National Institutes of Health (NIH); USDOE Office of Science (SC), Basic Energy Sciences (BES)
Grant/Contract Number:
AC02-06CH11357; SC0012704
OSTI ID:
1973499
Report Number(s):
BNL-224373-2023-JAAM
Journal Information:
ACS Chemical Neuroscience, Journal Name: ACS Chemical Neuroscience Journal Issue: 3 Vol. 14; ISSN 1948-7193
Publisher:
American Chemical Society (ACS)Copyright Statement
Country of Publication:
United States
Language:
English

References (77)

Treatment of Wilson's Disease With Ammonium Tetrathiomolybdate journal June 1994
Treatment of Wilson Disease With Ammonium Tetrathiomolybdate: III. Initial Therapy in a Total of 55 Neurologically Affected Patients and Follow-up With Zinc Therapy journal March 2003
Treatment of Wilson Disease With Ammonium Tetrathiomolybdate journal April 2006
Prevalence of cerebral amyloid angiopathy: A systematic review and meta‐analysis journal May 2021
Novel amyloid precursor protein mutation in an Iowa family with dementia and severe cerebral amyloid angiopathy journal January 2001
Cerebral amyloid angiopathy pathology and cognitive domains in older persons journal November 2010
Cerebral amyloid angiopathy in the elderly journal December 2011
Bis‐choline Tetrathiomolybdate as Old Drug in a New Design for Wilson’s Disease: Good for Brain and Liver? journal December 2018
Cerebral amyloid angiopathy and its relationship to Alzheimer’s disease journal March 2008
The molecular mechanisms of copper metabolism and its roles in human diseases journal June 2020
Copper and the brain noradrenergic system journal November 2019
The Pathophysiology and Clinical Presentation of Cerebral Amyloid Angiopathy journal May 2012
Biochemical, Histological, and Memory Impairment Effects of Chronic Copper Toxicity: A Model for Non-Wilsonian Brain Copper Toxicosis in Wistar Rat journal April 2013
Inhibition of ceruloplasmin and other copper oxidases by thiomolybdate journal December 1984
Mechanisms of selective copper removal by tetrathiomolybdate from metallothionein in LEC rats journal January 1996
Copper, iron and zinc in Alzheimer's disease senile plaques journal June 1998
UV/visible spectrophotometric studies of the interactions of thiomolybdates, copper(II) and other ligands journal May 2001
Metabolic fate of the insoluble copper/tetrathiomolybdate complex formed in the liver of LEC rats with excess tetrathiomolybdate journal January 2000
Stereological estimation of total microglia number in mouse hippocampus journal October 1998
Systemic Dispositions of Molybdenum and Copper after Tetrathiomolybdate Injection in LEC Rats journal October 1995
Wilson's disease and other neurological copper disorders journal January 2015
A Novel Transgenic Rat Model of Robust Cerebral Microvascular Amyloid with Prominent Vasculopathy journal December 2018
Deposition of amyloid β in the walls of human leptomeningeal arteries in relation to perivascular drainage pathways in cerebral amyloid angiopathy journal May 2016
Effects of tetrathiomolybdate and penicillamine on brain hydroxyl radical and free copper levels: A microdialysis study in vivo journal February 2015
Copper transport to the brain by the blood-brain barrier and blood-CSF barrier journal January 2009
Application of X-ray absorption and X-ray fluorescence techniques to the study of metallodrug action journal April 2021
Quantitative imaging approaches to understanding biological processing of metal ions journal August 2022
Diverse biological roles of the tetrathiomolybdate anion journal February 2021
Effects of copper on viability and functional properties of hippocampal neurons in vitro journal June 2017
Elevated labile Cu is associated with oxidative pathology in Alzheimer disease journal January 2012
Cerebral Amyloid Angiopathy journal August 2017
Synchrotron-based infrared and X-ray imaging shows focalized accumulation of Cu and Zn co-localized with β-amyloid deposits in Alzheimer’s disease journal July 2006
Metabolism and functions of copper in brain journal May 2014
Oxidative stress and the amyloid beta peptide in Alzheimer’s disease journal April 2018
Treatment of Wilson's disease with tetrathiomolybdate: V. control of free copper by tetrathiomolybdate and a comparison with trientine journal August 2009
Copper and Oxidative Stress in the Pathogenesis of Alzheimer’s Disease journal July 2012
Tracing Copper−Thiomolybdate Complexes in a Prospective Treatment for Wilson’s Disease journal January 2009
Tetrathiomolybdate Causes Formation of Hepatic Copper−Molybdenum Clusters in an Animal Model of Wilson's Disease journal January 2003
Quantification of the Binding Constant of Copper(II) to the Amyloid-Beta Peptide journal July 2008
Wilson disease journal September 2018
Copper(I)-binding properties of de-coppering drugs for the treatment of Wilson disease. α-Lipoic acid as a potential anti-copper agent journal January 2018
Copper handling machinery of the brain journal January 2010
Copper accumulation and the effect of chelation treatment on cerebral amyloid angiopathy compared to parenchymal amyloid plaques journal January 2020
A liver-targeting Cu(i) chelator relocates Cu in hepatocytes and promotes Cu excretion in a murine model of Wilson’s disease journal May 2020
PBT2 acts through a different mechanism of action than other 8-hydroxyquinolines: an X-ray fluorescence imaging study journal November 2020
Charge Alterations of E22 Enhance the Pathogenic Properties of the Amyloid β-Protein journal May 2000
Characterization of Copper Interactions with Alzheimer Amyloid β Peptides journal September 2008
Pathogenic Effects of D23N Iowa Mutant Amyloid β-Protein journal July 2001
Sequestration of Copper from β-Amyloid Promotes Selective Lysis by Cyclen-Hybrid Cleavage Agents journal November 2008
Copper stabilizes antiparallel β-sheet fibrils of the amyloid β40 (Aβ40)-Iowa variant journal July 2020
Metal (molybdenum, copper) accumulation and retention in brain, pituitary and other organs of ammonium tetrathiomolybdate-treated sheep journal April 1998
Increased Tunel Positive Cells in CA1, CA2, and CA3 Subfields of Rat Hippocampus Due to Copper and Ethanol Co-Exposure journal January 2008
Larch: An Analysis Package for XAFS and Related Spectroscopies journal April 2013
Two Types of Sporadic Cerebral Amyloid Angiopathy journal March 2002
X-ray fluorescence microscopy methods for biological tissues journal May 2022
Regulation of Copper Transport Crossing Brain Barrier Systems by Cu-ATPases: Effect of Manganese Exposure journal March 2014
ATHENA , ARTEMIS , HEPHAESTUS : data analysis for X-ray absorption spectroscopy using IFEFFIT journal June 2005
Review: Sporadic cerebral amyloid angiopathy: Cerebral amyloid angiopathy journal January 2011
Binding of zinc(II) and copper(II) to the full-length Alzheimer’s amyloid-β peptide journal March 2008
Sporadic and Familial Cerebral Amyloid Angiopathies journal April 2006
Tetrathiomolybdate Inhibits Copper Trafficking Proteins Through Metal Cluster Formation journal November 2009
Amyloid beta protein precursor gene and hereditary cerebral hemorrhage with amyloidosis (Dutch) journal June 1990
A Comparative Interaction between Copper Ions with Alzheimer'sβAmyloid Peptide and Human Serum Albumin journal January 2012
Correction: Influencing the Tumor Microenvironment: A Phase II Study of Copper Depletion Using Tetrathiomolybdate in Patients with Breast Cancer at High Risk for Recurrence and in Preclinical Models of Lung Metastases journal September 2020
Cerebral amyloid angiopathy: incidence and complications in the aging brain. I. Cerebral hemorrhage. journal November 1983
Cerebral amyloid angiopathy and cognitive outcomes in community-based older persons journal November 2015
Copper chelation in cancer therapy using tetrathiomolybdate: an evolving paradigm journal April 2009
Effect of Copper Overload Together with Ethanol Uptake on Hippocampal Neurons journal January 2003
Cerebral amyloid angiopathy–associated intracerebral hemorrhage: pathology and management journal April 2012
Elevated copper in the amyloid plaques and iron in the cortex are observed in mouse models of Alzheimer's disease that exhibit neurodegeneration journal January 2013
Chronic Copper Exposure Causes Spatial Memory Impairment, Selective Loss of Hippocampal Synaptic Proteins, and Activation of PKR/eIF2α Pathway in Mice journal December 2014
Copper Modulation and Memory Impairment due to Hippocampal Tau Pathology journal October 2020
Role of Copper in the Onset of Alzheimer’s Disease Compared to Other Metals journal January 2018
Tetrathiomolybdate Treatment Leads to the Suppression of Inflammatory Responses through the TRAF6/NFκB Pathway in LPS-Stimulated BV-2 Microglia journal February 2018
Interactions between Amyloid-Β Proteins and Human Brain Pericytes: Implications for the Pathobiology of Alzheimer’s Disease journal May 2020
Commonalities between Copper Neurotoxicity and Alzheimer’s Disease journal January 2021
Cerebral Amyloid Angiopathy: A Systematic Review journal January 2011